Asensus Surgical Announces Sale of Senhance Robotic System
“We're pleased to see the increasing adoption of Senhance by pediatric-focused hospitals. Senhance’s specialized technology such as 3mm instrumentation, 5mm camera scope, and advanced clinical intelligence, offers the potential to reduce invasiveness and enhance precision, particularly in pediatric patients," noted
Caption: A Senhance Surgical System will be placed in a pediatric hospital in the Commonwealth of Independent States (CIS) region.
Email Alerts: https://ir.asensus.com/email-alerts
This press release includes statements relating to the Senhance Surgical System and the sales of a Senhance System to be placed in a hospital in the Commonwealth of Independent States. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether we will be able to extend the Senhance System’s specialized technology to more pediatric hospitals and patients globally, ultimately contributing to an improved standard of patient care. For a discussion of the risks and uncertainties associated with the Company’s business, please review our filings with the
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e76f446f-e028-499f-ba7a-3ae25c9369c9
Source: Asensus Surgical, Inc.